Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply
Chris Estes(Center for Disease Analysis), Homie Razavi(Center for Disease Analysis), Henry Lik‐Yuen Chan(Radiant Research (United States)), Dae Won Jun, Rong‐Nan Chien(Chang Gung Memorial Hospital), Byoung Kuk Jang(Keimyung University), Jee‐Fu Huang(Kaohsiung Medical University), Tsung‐Hui Hu(National Sun Yat-sen University), Jia‐Horng Kao(National Taiwan University Hospital), James Fung(University of Hong Kong), Kathryn Razavi‐Shearer(Center for Disease Analysis), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Jin‐Woo Lee(Incheon Medical Center), Han‐Chieh Lin(Taipei Veterans General Hospital), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), George Boon‐Bee Goh(Singapore General Hospital), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Wan‐Long Chuang(Kaohsiung Medical University)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
|Hepatology|2017|2.4k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k